A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis

Aims The use of swollen (SJC) and tender joint counts (TJC) for rheumatoid arthritis (RA) disease activity and treatment effectiveness is well established. Patient‐reported outcomes (PRO) are important. However, it is unknown if patient scoring is as reliable as that of trained professionals. Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of rheumatic diseases 2019-01, Vol.22 (1), p.73-80
Hauptverfasser: Inderjeeth, Charles A., Inderjeeth, Adrisha J., Raymond, Warren D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims The use of swollen (SJC) and tender joint counts (TJC) for rheumatoid arthritis (RA) disease activity and treatment effectiveness is well established. Patient‐reported outcomes (PRO) are important. However, it is unknown if patient scoring is as reliable as that of trained professionals. Methods PRO including SJC and TJC were assessed at baseline, 6 and 12 weeks by patients and clinicians. Data were collected using ePRO (electronic) and pPRO (paper). The Least Squares Method (LSM), Pearson correlation (Rs) and weighted Kappa scores were used to assess inter‐rater reliability and agreement of responses between the patient, nurse and physician for changes in TJC and SJC from 0 to 12 weeks of treatment. Results There was a total of 341 evaluable matched joint assessment in 52 patients with RA: 157 nurse, 106 patient and 78 physician. There were matched joint count pairs for 104 patient‐nurse, 72 physician‐nurse and 21 patient‐physician. Correlation (R) of TJC scores were as follows: patient‐nurse 0.83 (P 
ISSN:1756-1841
1756-185X
DOI:10.1111/1756-185X.13364